The effects of expression of Drosophila melanoga ster Ca 2+ permeable transient receptor potential-like (TRPL) channels, under the control of the cytomegalovirus (CMV) or prostate cell-specific promoters, on cell survival and apoptosis in the androgen-sensitive LNCaP prostate cancer cell line were investigated. A prostate-specific antigen (PSA) promoter construct (designated PSAEn/PSAPr) composed of a 0.6 kb region of the promoter and a 1.45 kb region of the enhancer resulted in androgen-dependent and prostatespecific expression of a luciferase reporter gene in transiently transfected LNCaP cells. Expression of the enhanced green fluorescence protein-TRPL chimeric protein under the control of the CMV promoter was confirmed by Western blot. Whereas the majority of the expressed protein was located in the cytoplasmic space, confocal microscopy with the CD-9 protein as a plasma membrane marker demonstrated that approximately 10% of the expressed TRPL protein was located in a band in the plasma membrane. Using recombinant adenoviruses, expression of the TRPL protein was associated with an increase in both the initial and sustained rates of Ca 2+ inflow. Expression of TRPL under the control of the CMV promoter for 96 hours decreased cell number and increased the number of cells undergoing apoptosis by 23 and 27%, respectively. Apoptosis was inhibited by a caspase-3 inhibitor, Z-DEVD-fmk. It is concluded that, when heterologously expressed in LNCaP cells, the TRPL protein leads to a reduction in cell survival due, in part, to the induction of apoptosis. The effects of TRPL are likely caused by enhanced Na + and Ca 2+ inflow to the cells. This finding suggests a novel approach to modify the growth of prostate cancer cells that fail to undergo apoptosis following androgen ablation therapy.
I
nitially androgen ablation therapy for advanced prostate cancer leads to remission of the disease due to the induction of apoptosis. However, hormone refractory clones often arise, leading to renewed or ''androgenindependent'' growth of the cancer. Tumor cells that escape androgen ablation may maintain the capacity to undergo apoptosis with subsequent cycles of androgen ablation therapy 1, 2 or, in some cases, with chemotherapeutic agents. 3 Maintenance of the capacity to undergo apoptosis has important therapeutic implications.
Changes in intracellular Ca 2+ homeostasis in prostate cancer cells play an important role in the signalling events during the response to androgen ablation therapy and drug-induced apoptosis. 4, 5 There is evidence for a sustained increase in the cytoplasmic free Ca 2+ concentration ([Ca 2+ ] cyt ) in androgen-dependent normal prostate epithelial cells and androgen-dependent prostate cancer cells prior to the onset of apoptosis, and for a decreased apoptotic response when the extracellular Ca 2+ concentration is low. 2, 4, 5 The failure to initiate this increase in [Ca 2+ ] cyt following androgen ablation is believed to play an important role in the emergence of a hormone refractory phenotype. 6 In animal models, the Ca 2+ channel blocker nifedipine was found to inhibit castration-induced apoptosis and tumor regression. 7 Therefore, a potential therapeutic approach is to activate apoptosis by increasing [Ca 2+ ] cyt in hormone refractory prostate cancer cells, or even in androgen-dependent tumor cells prior to the development of resistance to androgen ablation.
In support of this approach, treatment of hormone refractory prostate cancer cells with thapsigargin has been shown to induce apoptosis. 6 Thapsigargin inhibits the endoplasmic reticulum (Ca 2+ +Mg 2+ )ATP-ase which, in turn, leads to the outflow of Ca 2+ from the endoplasmic reticulum, a decrease in the concentration of Ca 2+ in the lumen of endoplasmic reticulum, the activation of storeoperated Ca 2+ channels, and the induction of a sustained increase in [Ca 2+ ] cyt . 8 Although the initial events required for thapsigargin-induced apoptosis are not clearly defined, a sustained increase in [Ca 2+ ] cyt and/or the decrease in the concentration of Ca 2+ in the endoplasmic reticulum have been implicated. 6, 9 One or more of these changes are thought to trigger subsequent steps in the process of apoptosis including the activation of a network of intracellular proteases (e.g. caspases) and endonucleases, an increase in the concentration of Ca 2+ in the mitochondria matrix, and the release of cytochrome C from mitochondria. [10] [11] [12] An alternative way to induce a sustained increase in [Ca 2+ ] cyt is to overexpress a constitutively active plasma membrane Ca 2+ permeable channel such as the transient receptor potential-like (TRPL) protein. TRPL is a nonselective cation channel that is found in the photoreceptor cells of Drosophila melanogaster. 13 Together with the transient receptor potential (TRP), TRPL is required in the phototransduction process. A number of mammalian cell homologues to the TRP protein have been identified although their functions are not well understood. 14 When expressed in the environment of some animal cells, the Drosophila TRPL protein is constitutively active and mediates Ca 2+ and Na + inflow. This constitutive activity is thought to be due to differences between the environment of the Drosophila photoreceptor cell and the host animal cell, which lead to altered regulation of the opening of the TRPL channels. [15] [16] [17] The constitutive activity of TRPL causes a sustained increase in [Ca 2+ ] cyt , which can kill the transfected cells. [15] [16] [17] The aim of the present study was to express the Drosophila TRPL nonselective cation channel in a prostate cancer cell line and to test whether this leads to apoptosis and decreased cell survival. The experiments have been conducted using LNCaP cells, and a replication-deficient adenovirus to deliver TRPL cDNA into LNCaP cells. Adenoviruses have the ability to infect both dividing and nondividing cells with high efficiency. 18 Two types of promoters were employed: the strong constitutively active cytomegalovirus (CMV) promoter 19 and several prostate cell-specific promoters. We report that transient expression of TRPL in LNCaP prostate cancer cells results in an increase in apoptosis and a decrease in cell number, suggesting that this may provide a novel approach to inhibit the growth of prostate tumors.
Methods

Materials
Drosophila TRPL cDNA were kindly provided by Dr Len Kelly, Department of Genetics, University of Melbourne, Parkville, Victoria, Australia. Ad Easy adenovirus system was kindly provided by Dr Tong-Chuan He, Howard 
Cell culture
Human prostate cancer LNCaP cells (ATCC, CRL-1740) and PC-3 cells (ATCC, CRL-1435) were grown in RPMI medium 1640 (GIBCOBRL) supplemented with 10% (v/v) FCS, 100 U/ml penicillin, and 100 mg/ml streptomycin. Human embryonic kidney (HEK 293) cells (ATCC, CRL-1573) and rat H4-IIE liver cells (ATCC, CRL-1548) were grown in Dulbecco's modified Eagle's medium (GIBCOBRL) supplemented with 10% (v/v) FCS, 100 U/ml penicillin, and 100 mg/ml streptomycin. Androgen dose-response experiments were conducted in antibiotic-free RPMI medium 1640 supplemented with charcoal-stripped FCS (10% v/v). Dihydrotestosterone (DHT) was dissolved in 100% ethanol, then diluted to the required concentration in this medium. The cell lines used for experiments were transferred through less than 30 passages.
Molecular biological constructs and cell transfections
Prostate-specific promoter-luciferase constructs. All the constructs used are listed in Table 1 . The PSA promoter (PSAPr) region stretches from base À630, EcoRI site, to +6, HindIII site (relative to the transcription start site) of the PSA gene. The probasin promoter (PROBPr) used contains three copies of 5 0 sequences head to tail from À244 to À96 (relative to the transcription start site) of the probasin gene. The PSAPr was subcloned as a HindIII/ XhoI fragment into pGL3-basic (promoterless) or pGL3-enhancer (containing a simian virus 40 (SV40) enhancer) firefly luciferase expression vector (Promega) to give plasmid pGL-PSAPr-Luc or pGL-PSAPr-Luc-SV40. The PROBPr was subcloned as a SacI/SmaI fragment into pGL3-basic vector to generate pGL-PROBPr-Luc.
The PSA enhancer (PSAEn) sequence extends from XbaI site -5322 to PSP 1406 I site at -3870 of PSA gene (relative to the transcription start site). PSAEn was cloned into the SacI/SmaI site upstream of PSA promoter in pGL-PSAPr-Luc and pGL-PSAPr-Luc-SV40 to generate pGL-PSAEn/PSAPr-Luc and pGL-PSAEn/PSAPr-Luc-SV40, or the BamHI site downstream of SV40 poly A in the pGL-PSA-Luc and pGL-PSA-Luc-SV40 to generate pGL-PSAPr-Luc-PSAEn and pGL-PSAPr-Luc-SV40-PSAEn, respectively.
Construction of enhanced green fluorescence protein (EGFP)-TRPL and TRPL-EGFP chimeras. Trpl cDNA was inserted into the XbaI site downstream of EGFP in pEGFP-C1 (Clontech), which contains an EGFP to generate pCMV-EGFP-TRPL chimera. The correct orientation of TRPL cDNA in this construct was confirmed with restriction enzyme digestion and PCR. To generate pCMV-TRPL-EGFP chimera, TRPL cDNA was inserted into EcoRI/SalI sites upstream of EGFP in pEGFP-N1 (Clontech). Measurement of the activity of luciferase reporter protein cDNA containing a given promoter construct inserted in the pGL3 basic or pGL3 enhancer firefly luciferase reporter plasmid was prepared as described above. The pRL-CMV plasmid (Promega) encoding a Renilla luciferase reporter protein under the control of the CMV promoter was used as an internal control for transfection efficiency. LNCaP cells were cotransfected with firefly luciferase reporter plasmid containing a given prostatespecific promoter (2 mg) and the pRL-CMV Renilla luciferase reporter plasmid (0.02 mg). At 48 hours after transfection, luciferase activity was measured using the Dual-luciferase TM Reporter Assay System (Promega) following the manufacturer's instruction in a Topcount TM microplate scintillation counter (Packard). Firefly luciferase activity in each sample was normalized for variations in transfection efficiency by measuring the activity of Renilla luciferase in the same sample.
Anti-TRPL antibody, Western blot analysis, and immunofluorescence
A peptide (CDSNFDIHVVDLDEK) corresponding to the 15 C-terminal acids of Drosophila TRPL 21 was synthesized (Chiron Technologies, Clayton, Victoria) and coupled to the carrier diphtheria toxoid. An initial dose of 1000 mg peptide was injected subcutaneously into rabbits followed by three boosts of 500 mg each at two weekly intervals and a fourth boost at 3 months after initial injection. Serum was collected after the third boost and fourth boost and subsequently, as necessary. The IgG fraction was separated from other serum proteins by (NH 4 ) 2 SO 4 precipitation and purified by binding to an affinity column, composed of the immunizing peptide bound to epoxy-activated sepharose 6B (Pharmacia), followed by elution with 4.9 M MgCl 2 . 22 For Western blots, cells were harvested by 0.1% (w/v) trypsin and 0.2% (w/v) EDTA then washed two times with 1 Â PBS. Cells were lysed by sonication in lysis buffer which consisted of 5 mM Tris-HCl, pH 7.4, 5 mM EDTA, 0.1% (w/v) SDS, 1% (v/v) Triton-100, 100 mM phenylmethysulfonyl-fluoride (PMSF), 20 mM leupeptin, 20 mM pepstatin A, 0.00125% (w/v) bromophenol blue, and 0.1% (v/v) b-mercaptoethanol. Samples of lysate (40 mg of protein) were subjected to SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to a nitrocellulose membrane (Hybond C+) by semidry blotting (Horiz Blot, Atto Corporation, Japan). The membrane was blocked with 5% (w/v) skim milk, 0.1% (v/v) Tween 20 in Tris-buffered saline (TBS-T) and incubated with anti-TRPL (1:100) antibody or anti-TRPL antibody plus antiactin antibody (1:500) overnight at 41C. The membrane was washed three times with TBS-T and incubated with anti-rabbit IgG secondary antibody conjugated to peroxidase (1:1000, Sigma). Bands were visualized by the enhanced chemiluminescence 23 Western blot detection system (Amersham Pharmacia Biotech).
For immunofluorescence, cells were grown on glass coverslips and transfected as described above. At 48 hours after transfection, cells were fixed with 4% (w/v) paraformaldehyde, blocked with 20% (v/v) FCS and incubated with anti-TRPL antibody (1:100 dilution) at 41C overnight, then with anti-rabbit IgG secondary antibody conjugated with Cy3 (1:400 dilution) for 2 hours at room temperature.
Confocal microscopy
For colocalization experiments, immunocytochemistry of pCMV-EGFP-TRPL-transfected cells was performed using a monoclonal antibody to CD-9 antigen to stain the plasma membrane. 24 Briefly, cells were fixed and blocked as described above. Then cells were incubated with 1:40 dilution of anti-CD-9 antibody at 41C overnight and anti-mouse IgG secondary antibody conjugated with Cy3 (1:400 dilution) for 2 h at room temperature. Cells were viewed in an Olympus AX70 microscope attached to a BioRad 1024 scanning confocal system equipped with an Argon Ion (488 nm) and a Helium Neon (543 nm) laser for excitation and detection of EGFP and Cy3 fluorescence, respectively. Images were collected in the middle part of the cells.
Measurement of the [Ca 2+ ] cyt and rates of Ca 2+ inflow
Infected LNCaP cells were harvested by treatment with 0.1% (w/v) trypsin and 0.2% (w/v) EDTA and washed twice with Krebs-Ringer-Hepes medium (125 mM NaCl (except where indicated otherwise), 5 mM KCl, 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 1.2 mM CaCl 2 , 6 mM glucose, and 25 mM Hepes-NaOH buffer, pH 7.4). Cells (2 Â 10 6 cell/ml) in 2 ml aliquot were then loaded for 30 min at 371C with the acetoxymethyl ester of fura-2 (5 mM) in Krebs-Ringer-Hepes medium with shaking (90 cycles/min), and subsequently washed twice with KrebsRinger-Hepes medium. Fura-2 fluorescence was measured using a Perkin-Elmer LS50B spectrofluorimeter as described previously. 15 Values of fluorescence ratio (excitation wavelengths 340/380 nM, emission wavelength 510 nM) were converted to [Ca 2+ ] cyt as described previously. 25 ] cyt as a function of time following the addition of thapsigargin. All slopes were determined by linear regression.
Measurement of the cell number, nuclear condensation and fragmentation, and caspase activity Cell number was measured using MTT colorimetric dye reduction method. This assay is dependent on the ability of mitochondrial dehydrogenases within viable cells to reduce the MTT dye to a purple formazan product. The rate of formazan dye increase is directly correlated to the number of viable cells, as determined by others. 26 Cells were grown in a 96-well plate. MTT (10 ml of 10 mg/ml) was added to each well, and the plate incubated at 371C for 4 hours. SDS (20% (w/v) in 0.02 M HCl) was then added to each well to solubilize the crystals. After overnight incubation at room temperature, the absorbance was read at 570 nm using a BioRad 450 multiwell plate reader.
Nuclear condensation and fragmentation was examined by assessing the nuclear morphology of infected cells. 27 Cells grown on coverslips were fixed with paraformaldehyde (4% w/v), stained for 5 minutes with Hoechst 33258 (5 mg/ml), then examined by fluorescence microscopy. Infected cells were identified by the fluorescence of expressed EGFP, and cells exhibiting nuclear condensation and fragmentation were identified using the dye Hoechst 33258. 28 Fluorescence microscopy was performed using an Olympus AX70 fluorescence microscope and Â 20 objective lens. The excitation and emission wavelengths were set at 340/80 and 435/85 nm, respectively, for Hoechst 33258, and at 470/90 and 515/45 nm, respectively, for EGFP. Caspase-3 inhibitor, Z-DEVDfmk was dissolved in 1 Â PBS and filter sterilized. Z-DEVD-fmk (100 mM) was added to the cells immediately after viral infection.
Caspase activity assay was assayed using a caspase fluorogenic substrate Z-DEVD-AFC. At 96 hours after infection, cells were harvested by treatment with 0.1% (w/ v) trypsin and 0.2% (w/v) EDTA. The supernatant was aspirated and 100 ml caspase assay buffer (50 mM Tris, 1 mM EDTA, 10 mM EGTA, pH 7.4 at 41C) was added. Cells were then sonicated (1 Â 5 seconds XL2020 sonicator from Hert Systems) and added to a 96-well plate. Sonicate 10 ml was taken and used in a protein determination. Caspase assay buffer containing fluorogenic substrate (100 ml of 50mM Z-DEVD-AFC, 50 mM Tris, 1 mM EDTA, 10 mM EGTA, pH 7.4 at 371C) was then added to 85 ml of cell lysate. The level of relative fluorescence was measured over an hour in a Perkin-Elmer LS50B spectrofluorimeter with excitation at 400 and emission at 505 nm. The relative fluorescence U/mg protein/minute were determined and used as a measure of the level of caspase activation.
Expression of results
Except where indicated otherwise, results are expressed as the mean7SEM of the number of determinations indicated. Degrees of significance were determined using unpaired two-tailed Student's t-test. Values of Po.05 were considered to be significant.
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Results
Identification of prostate cell-specific promoter and enhancer sequences for the selective expression of the TRPL protein in LNCaP cells
In order to identify prostate cell promoter sequences that would yield a selective and substantial expression of the TRPL protein in LNCaP cells, cDNA encoding several different prostate cell-specific promoters was incorporated into the pGL-3 vector and the ability of each promoter construct to induce expression of the luciferase reporter gene was tested. The promoters chosen were a 0.6 kb region (nucleotides À630 to +6) of the PSA gene promoter 29 (designated the PSAPr promoter), a 1.45 kb sequence (nucleotides À5322 to À3870) of the PSA gene encoding the PSA enhancer 30 (designated the PSAEn promoter), and a sequence consisting of three copies of a 150 bp region of the 5 0 region of the probasin gene 31 (designated the PROBPr promoter). These and the other promoter constructs and vectors used in this study are listed in Table 1 . With 10% (v/v) FCS present in the culture medium (giving approximately physiological concentrations of androgen), the PSAPr sequence increased the expression of luciferase four-fold (Table 2) , whereas combinations of the PSAPr and PSAEn sequences (PSAEn/PSAPr-Luc and PSAPr-Luc-PSAEn) and the probasin promoter each increased the expression of luciferase 600 to 2000-fold ( Table 2) . Inclusion of the SV40 enhancer sequence in the plasmid containing the PSAPr sequence and in the plasmid containing the PSAEn/PSAPr construct did not substantially further enhance luciferase expression ( Table 2) .
The ability of each of the PSAEn/PSAPr, PSAPr-LucPSAEn, and PROBPr constructs to promote the expression of luciferase specifically in prostate cancer cells was tested using the androgen-sensitive LNCaP cell line, the androgen-insensitive PC-3 prostate cancer cell lines, and the human embryonic kidney (HEK) 293 and rat liver H4-IIE cell lines. All three promoter/enhancer combinations gave substantial expression of luciferase in androgensensitive LNCaP cells (Table 3 ). In androgen-insensitive PC-3 cells, luciferase expression driven by the PSAEn/ PSAPr, the PSAPr-Luc-PSAEn and the PROBPr promoter constructs was comparable with that in cells expressing the pGL-3 basic empty vector ( Table 3 ). The Table 2 . It is likely that these differences are due to different concentrations of androgen present in the FCS media employed since all the prostate-specific promoters tested are androgen-dependent and the concentration of endogenous androgen (e.g. DHT) in different batches of FCS may vary.)
Expression of Drosophila TRPL protein L Zhang et al relatively low expression of luciferase in the presence of an appropriate promoter in PC-3 cells is likely due to the low expression of the androgen receptor or to the lack of a functional androgen receptor in this cell line. 32 In HEK 293 and H4-IIE cells, luciferase expression driven by the PSAEn/PSAPr, PSAPr-Luc-PSAPr and PROBPr promoter constructs was less than about 10, 10 and 20%, respectively, of that in LNCaP cells (Table 3 ). The PROBPr promoter construct gave some expression of luciferase in HEK 293 cells (Table 3) .
The dependence on androgen of the ability of each of the PSAEn/PSAPr, PSAPr-Luc-PSAEn and the ProbPr constructs to promote luciferase expression was tested using exogenous androgen (DHT) and a culture medium that contained charcoal-stripped FCS (i.e. no endogenous androgen). A concentration of 100-500 nM DHT gave near-maximal expression of luciferase (Fig 1) . Luciferase activity decreased from the maximal value when the concentration of DHT was increased further to 1000 nM (Fig 1) .
Expression of the TRPL protein in transiently transfected LNCaP cells
To study the amount of TRPL protein expressed in LNCaP cells and its intracellular localization, pCMV-EGFP-TRPL (containing cDNA encoding the EGFP-TRPL chimeric protein) or pCMV-TRPL-EGFP (containing cDNA encoding the TRPL-EGFP chimeric protein) were transiently transfected into LNCaP cells and the cells were grown in culture medium, that contained 10% (v/v) FCS (i.e. at physiological concentrations of androgen). Western blot analysis showed that at 48 hours after transfection, bands at 155 kDa, corresponding to the predicted sizes of the EGFP-TRPL and TRPL-EGFP chimeras, were detected in cell lysates (Fig  2a) . For comparison, the Drosophila TRPL protein was detected as a band with an apparent molecular weight of 128 kDa (Fig 2a) . 21 To investigate the intracellular distribution of TRPL, pCMV-EGFP-C1 and pCMV-EGFP-TRPL were transiently transfected into LNCaP cells and EGFP fluorescence and TRPL immunofluorescence were examined after 48 hours. In LNCaP cells transfected with cDNA encoding EGFP alone, EGFP fluorescence was distributed throughout the cell (Fig 2b, panel 3) , while little immunofluorescence was detected with the anti-TRPL antibody (Fig 2b, panel 1) . In cells transfected with the pCMV-EGFP-TRPL construct, the distribution of EGFP was located in the cytoplasmic space and at the plasma Expression of Drosophila TRPL protein L Zhang et al membrane with little or none in the nucleus (Fig 2b, panel  4) . The distribution of immunofluorescence detected using an anti-TRPL antibody was similar to that of the EGFP fluorescence (Fig 2b, panel 2 cf. Fig 2b, panel 4) . Results similar to those shown in Figure 2b were obtained for LNCaP cells transfected with the pCMV-TRPL-EGFP construct (data not shown), indicating that the localization of TRPL was not influenced by whether the EGFP moiety is located at the N-or C-terminus of TRPL. Results similar to those shown in Figure 2b were also obtained in similar experiments conducted using HEK 293 and PC-3 cells (data not shown), suggesting that the intracellular localization of TRPL observed in LNCaP cells is not unique to this cell type.
Confocal microscopy was employed to further characterize the intracellular location of the expressed TRPL protein. The distribution of EGFP fluorescence in cells transfected with pCMV-EGFP-TRPL or with pCMV-EGFP-C1 is shown in Figures 3a and d, respectively . EGFP fluorescence appears to fill the cytoplasmic space and nucleus (more concentrated in the nucleus) in cells transfected with pCMV-EGFP-C1 (Fig 3d) . In cells transfected with pCMV-EGFP-TRPL, the majority of expressed TRPL protein is associated with a reticular structure outside the nucleus (Fig 3a) . In order to define the location of the plasma membrane more clearly, the cells were treated with an antibody against the CD-9 protein, that is located on the plasma membrane in a number of cell types. 24, 33 Immunofluorescence images of LNCaP cells treated with the anti-CD-9 antibody revealed a clear location of the CD-9 protein at the plasma membrane of cells transfected with pCMV-EGFP-TRPL (Fig 3b) and cells transfected with pCMV-EGFP-C1 (Fig  3e) . Overlay of the CD-9 and EGFP-TRPL images for each cell transfected with pCMV-EGFP-TRPL showed that the EGFP-TRPL chimeric protein and the CD-9 protein are colocated at the plasma membrane in a band (about 30-50% of the plasma membrane) of the cell (Fig 3c, indicated by the orange color (arrows) ). This pattern of colocalization was consistently observed (Fig 3,  legend) . Some colocalization of EGFP fluorescence and CD-9 immunofluorescence was also observed in control cells (transfected with pCMV-EGFP-C1) (Fig 3f) . However, the region of colocalization was much smaller than that attributed to the colocalization of EGFP-TRPL and CD-9 and was randomly located from one cell to another. Some colocalization of EGFP with the plasma membrane is not surprising because in most cell types, the fluorescence of EGFP appears to homogeneously fill the cytoplasmic space, nucleus, and in neurons, distal process such as neurites. 34 
Expression of TRPL in LNCaP cells infected with adenovirus containing cDNA encoding TRPL
Western blot analysis of LNCaP cells infected with
Adenovirus-CMV-TRPL (in which TRPL expression is controlled by the strong CMV promoter) showed that at 96 hours after transfection, a band at 128 kDa, corresponding to the predicted size of the Drosophila TRPL Expression of Drosophila TRPL protein L Zhang et al protein was detected in cell lysates (Fig 4, lane 3 ) (cf the 128 kDa band observed for TRPL in extracts of Drosophila heads (Fig 4, lane 4) ). In cells infected with Adenovirus-PSAEn/PSAPr-TRPL (in which TRPL expression is under control of the PSAEn/PSAPr promoter), Western blot analysis also revealed a 128 kDa band corresponding to TRPL (Fig 4, lane 2) . However, the intensity of this band was about eight-fold lower than that of the TRPL protein in lysates of cells infected with Adenovirus-CMV-TRPL (Fig 4, lane 2 cf lane 3) . The appearance of each of the bands corresponding to TRPL was blocked by preincubation of the anti-TRPL antibody with the peptide used to generate the antibody (Fig 4,  lanes 5-8) . The equal amount of b-actin detected in all the samples indicates that the amount of protein loaded was same in each lane. The results of the Western blot, EGFP-TRPL chimera fluorescence imaging, and immunofluorescence imaging experiments indicate that the TRPL protein can be expressed in LNCaP cells. While most of the expressed TRPL protein appears to be in the cell interior, some are located at the plasma membrane.
Effect of TRPL expression on Ca 2+ inflow
To determine the effect of TRPL expression on Ca 2+ inflow, LNCaP cells were loaded with fura-2 and incubated in the absence of added extracellular Ca 2+ , while recording fura-2 fluorescence as a function of time (Fig 5) . Extracellular Ca 2+ was then added to initiate Ca 2+ inflow, and fura-2 fluorescence measured for a further 25 minutes. Cells infected with Adenovirus-CMV-TRPL exhibited considerably faster initial and sustained rates of Ca 2+ inflow compared with control cells (infected with Adenovirus-PSAEn/PSAPr-Luc) (Fig 5 and Table 4 ). Faster initial and sustained rates of Ca 2+ inflow were also observed for cells infected with Adenovirus-PSAEn/ PSAPr-TRPL (in which TRPL expression is under control of the PSAEn/PSAPr promoter construct) (Table 4) . However, the magnitude of the increase in the sustained rate of Ca 2+ inflow was less than that observed when TRPL was under the control of the CMV promoter ( Table 4) . The results shown in Figure 5 also inflow were also measured in cells incubated in a medium that contained 40 instead of 125 mM Na + (employed for the experiments shown in Fig 5) . The results ( , and extracellular Ca 2+ (2 mM) was added at the time indicated by the arrow. The results shown are representative of one of three experiments, which gave similar results.
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Since a considerable amount of the expressed TRPL protein was located at intracellular membranes, the possibility that this affects the release of Ca 2+ from intracellular stores was investigated. Thapsigargin (10 mM) was added to cells loaded with fura-2 and incubated in the absence of added extracellular Ca 2+ . For cells infected with Adenovirus-CMV-TRPL(72 hours after transfection) and control cells (infected with Adenovirus-PSAEn/PSAPr-Luc), the amount of Ca 2+ released by thapsigargin (assessed by the height of the peak of increased [Ca 2+ ] cyt ) was 10607260 and 12407320 nM (means7SEM, n ¼ 3), respectively, and the rate of increase in [Ca 2+ ] cyt was 14707340 and 16807250 nM/min, respectively. These results indicate that expression of the TRPL protein did not detectably alter the amount of Ca 2+ in thapsigargin-releasable stores.
Effect of TRPL expression on cell number and apoptosis
To determine the effect of TRPL expression on cell number, LNCaP cells were infected with Adenovirus-CMV-TRPL, Adenovirus-PSAEn/PSAPr-TRPL, or Adenovirus-PSAEn/PSAPr-Luc (control). At 24, 48, and 96 hours after infection, the cells were incubated with MTT in order to assess the number of viable cells. (MTT is reduced by a mitochondrial dehydrogenase to an insoluble purple formazan dye that precipitates as crystals. This reaction can only be carried out by viable cells. The rate of formazan dye formation (assayed by reading the absorbance at 570 nM) is therefore proportional to cell number and reflects the viability of cell population). To examine the effect of TRPL expression on apoptosis, LNCaP cells infected with recombinant adenovirus and cultured for 96 hours were fixed and stained using the Hoechst 33258 dye. Infected cells were identified by EGFP fluorescence and their nuclear morphology examined. Figure 6 shows photomicrographs of EGFPpositive cells (a, b, and c) and Hoechst 33258-stained nuclei (d, e, and f). Condensed and fragmented nuclei are clearly visible in Adenovirus-PSAEn/PSAPr-TRPL (Fig  6e) and in Adenovirus-CMV-TRPL-infected cells (Fig 6f)  (compared with control cells, Fig 6d) . In cells infected with Adenovirus-PSAEn/PSAPr-Luc, AdenovirusPSAEn/PSAPr-TRPL, and Adenovirus-CMV-TRPL, the number of apoptotic cells was 3.570.5, 16.673.5, and 25.572.8% of the total number of infected cells, respectively (n ¼ 3, Po.05 (Student's t-test for unpaired samples)).
Role of caspases in TRPL-induced apoptosis
Caspases, a group of cysteine proteases, are essential for apoptosis in a variety of species. 34 They can be divided into two groups -those with large prodomains that function as initiators of the apoptosis cascade (e.g. caspase-2 and -9) and those with a small prodomain that act downstream as effectors (e.g. caspases-3, -6, and -7). 35 Caspase-3 and -7 are the best characterized effector caspase members involved in prostate cancer cell apoptosis. 10, 36 On the basis of substrate specificity, three classes of caspases have been defined. 37, 38 The substrate DEVD-AFC is efficiently hydrolyzed only by the class II caspases (i.e. caspase-3, -7 and -10). 37, 38 To evaluate whether TRPL-induced apoptosis is associated with the activation of class II caspases, LNCaP cells expressing TRPL were lysed at 96 hours and the hydrolysis of DEVD-AFC was measured. The activity of caspase (relative fluorescence units/mg protein/minute (RFU)) was increased 2.4-and 4.5-fold in lysates of cells infected To investigate the role of caspase-3 in apoptosis induced by TRPL expression, a specific inhibitor of caspase-3, Z-DEVD-fmk 39 , was incubated with cells infected with Adenovirus-CMV-TRPL, and the number of cells undergoing apoptosis at 96 hours after infection was examined. Infected cells were identified by EGFP fluorescence, and their nuclear morphology examined. The results are shown in Figure 7 . In the presence of Z-DEVD-fmk, the number of cells exhibiting condensed nuclei was reduced (Fig 7d cf Fig 7b) . The number of infected cells exhibiting condensed and fragmented nuclei was determined as a percentage of EGFP-positive cells. In the absence of Z-DEVD-fmk, 27.175.3% (n ¼ 3) of Adenovirus-CMV-TRPL-infected cells exhibited nuclear condensation and fragmentation. This was decreased to 12.573.9% (n ¼ 3) in the presence of 100 mM Z-DEVDfmk (Po0.05, Student's t-test for unpaired samples). In the control cells, only 3.870.3% (n ¼ 3) of infected cells exhibited nuclear condensation and fragmentation and this was not significantly altered (3.670.09% (n ¼ 3)) by the presence of Z-DEVD-fmk. These results implicate caspase-3 in the apoptosis induced by TRPL expression. However, the amount of apoptosis inhibited by 100 mM Z-DEVD-fmk was only 50%, suggesting that other caspases are involved in this form of apoptosis and caspase-independent apoptosis may occur.
Discussion
The new findings reported here are that expression of the Ca 2+ -permeable TRPL protein induces decreased cell survival in prostate cancer cells and this is associated with enhanced Ca 2+ inflow across the plasma membrane. The expression of TRPL in LNCaP cells under the control of the CMV promoter in an adenoviral vector led to a significant decrease in the number of cells present at 96 hours after infection. When the infection efficiency (about 60-70%) is taken into account, it can be estimated that expression of TRPL decreases the total cell number by about 40%. The Hoechst 33258 staining revealed that about 30% of cells expressing TRPL exhibit nuclear condensation and fragmentation, a clearly defined characteristic of apoptosis. 27 Therefore, it can be concluded that TRPL expression induced substantial apoptosis. Expression of the TRPL protein was associated with enhanced basal (no agonist present) initial and sustained rates of Ca ] cyt under physiological conditions. Expression of TRPL under the CMV promoter led to a greater reduction in cell number and to a greater proportion of apoptotic cells than expression of TRPL under the PSAEn/PSAPr promoter. This is consistent with greater expression of the TRPL protein under the control of the CMV promoter and suggests that the degree of cell killing is dependent on the amount of TRPL expressed. Moreover, larger increases in the rate of Ca 2+ inflow and basal [Ca 2+ ] cyt were observed in cells expressing TRPL under the control of the CMV promoter than those observed when expression was under the control of the prostate-specific promoter.
The observation that the activity of class II caspases was increased in cells expressing TRPL indicates that the activation of an effector caspase is associated with TRPLinduced apoptosis. One candidate for the effector caspase is caspase-3 since nuclear condensation and fragmentation were inhibited by the caspase-3 inhibitor Z-DEVDfmk. Since high [Ca 2+ ] cyt has been shown to induce nuclear fragmentation and to activate caspase, 40 and expression of TRPL induced a constitutive Ca 2+ influx, a role for Ca 2+ inflow and an increased [Ca 2+ ] cyt is implicated in TRPL-induced apoptosis. In addition, the inflow of Na + to the cytoplasmic space may also contribute to the observed apoptosis since TRPL is a nonselective cation channel that admits Na + as well as Ca 2+ . 41 An increase in the cytoplasmic-free Na + concentration, induced by anti-Fas antibody, has been shown to cause depolarization of the plasma membrane, subsequent loss of cytoplasmic K + , and apoptosis in Jurkat T-cells. 42 -selective member of  the TRP family such as TRPV5, TRPV6 or possibly  TRPC5 or TRPV1. 14 However, while heterologously expressed TRPL is often constitutively active, [15] [16] [17] it is less clear whether TRPV1, TRPV5, TRPV6, or TRPC5 are constitutively active.
The most effective prostate cell-specific promoter (assessed by expression of luciferase) was found to be the PSAEn/PSAPr construct. The ability of PSAEn/ PSAPr to promote luciferase expression was dependent upon the presence of DHT (androgen). However, a biphasic dose-response curve was observed with maximal expression of luciferase at 100 nM DHT and lower than maximal expression observed at DHT concentrations greater than 100 nM. This dose-response curve is consistent with results obtained by others for the regulation of androgen-dependent protein expression in LNCaP cells in culture [44] [45] [46] (but see Pang et al
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. Western blot analysis indicated that more TRPL protein is expressed under the control of the relatively strong CMV promoter than under the control of the PSAEn/ PSAPr prostate cell-specific promoter construct. This is consistent with the observations of others that have shown that tissue-specific promoters are often less effective than viral promoters when introduced into vectors. 44 While some expressed TRPL was found at the plasma membrane, the majority was located at intracellular sites. The results of experiments employing the plasma membrane marker, CD-9, indicate that in most cells examined, TRPL found at the plasma membrane is located on only one side of the cell. Lan et al reported a similar finding in Xenopus oocytes, in which a majority of the expressed TRPL protein was found in the vegetal hemisphere. 47 The TRPL polypeptide contains several ankyrin-like repeat domains 13 and ankyrin is required for targeting TRPL to the plasma membrane. 13 Ankyrins are a family of membrane-associated adapter proteins 48 that bind via their membrane-binding domains to diverse proteins including ryanodine 49 and Ins1,4,5P 3 50 receptors. In the Drosophila photoreceptor cell, TRPL is located in the microvilli of rhabdomeres (specialized portions of the plasma membrane of Drosophila photoreceptor that contain rhodopsin photopigments and other components of the phototransduction cascade) but not in other regions of the photoreceptor cell plasma membrane. 21 Both Drosophila and mammalian photoreceptor rhabdomeres are highly enriched in ankyrin and F-actin 51, 52 and these cytoskeletal proteins are thought to contribute to the polarized distribution of TRPL. 13 In polarized prostate epithelial cells ankyrin is confined to the basolateral plasma membrane and is absent from the apical membrane. 51 In human prostate cancer PPC-1 and ALVA-31 cells, ankyrin is colocalized with the hyaluronic acid receptors only on the one side of plasma membrane. 53 LNCaP cells are derived from lymph node metastasis of a hormone-refractory prostatic adenocarcinoma treated with estrogen and have been shown to exhibit a number of the functions of prostate epithelial cells. This suggests that LNCaP cells may have retained some of the polarization features of prostate epithelial cells including the polarized distribution of ankyrin. 54 Therefore, the localization of heterologously expressed TRPL to one side of the LNCaP cell surface may be due to the polarized location of ankyrin, actin, and other cytoskeleton proteins in these regions of the cell surface (i.e. by targeting mechanisms similar to those responsible for locating TRPL in the microvilli of the Drosophila photoreceptor cell and by ankyrin-TRPL interactions). TRPL present in the cell interior was found to be chiefly associated with a reticular structure outside the nucleus (cf Wang et al 55 ). There are several possible reasons for location of the expressed TRPL protein in the cell interior. The most likely explanation is that this distribution of heterologously expressed TRPL reflects the process responsible for the distribution of TRPL between an intracellular compartment and the rhabdomere of the Drosophila photoreceptor cell. 56 Other possibilities are that the synthesis of large amounts of TRPL may saturate the mechanisms that traffic newly synthesized proteins with targeting signatures like those of TRPL to the plasma membrane; targeting signatures of TRPL may not be recognized by the machinery of LNCaP cells; there may be inappropriate post-translational modification of TRPL (cf Wang et al 55 ) ; and/or TRPL in the reticular structure may represent newly synthesized protein normally found in this location.
In conclusion, the present findings indicate that expression of the heterologous TRPL nonselective cation channel has the potential to kill prostate cancer cells. This may provide a novel strategy for the treatment of prostate cancer that could be used to circumvent the failure of tumor cells to undergo apoptosis following initiation of conventional androgen ablation therapy.
